Using chromosome rearrangements as tumour-specific markers for disease monitoring in lung cancer using droplet digital PCR

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1139777

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

There are no useful markers apart from CT scans to determine the effectiveness of therapy in patients with lung cancer. We plan to assess highly sensitive methods that can examine the blood to determine whether DNA from the patient’s tumour is present. This will allow more responsive modulation of therapy to enable better management of the cancer.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Project Grants

Funding Amount: $1,081,335.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | lung cancer | minimal residual disease | molecular diagnostics | molecular pathology

Related Links